期刊文献+

肿瘤细胞培养上清对CIK细胞活性影响的研究 被引量:1

Effcets of cultural supernanant of tumor cells on activity of cord blood CIK cells
下载PDF
导出
摘要 目的 探讨两种血液肿瘤细胞K5 6 2和HL 6 0培养上清液对脐带血CIK细胞的影响作用。方法 在细胞因子诱导的脐带血杀伤细胞 (CIKs)形成的过程中 ,加入肿瘤细胞培养上清 ,观察CIK细胞的生长情况 ,并同正常培养条件下的CIK细胞比较增殖倍率、免疫表型及杀伤活性。结果 脐带血CIK细胞是以CD3+ T细胞为主的异质性细胞群体。随培养时间延长 ,CD3+ CD5 6 + 细胞比例明显升高。K5 6 2和HL 6 0培养上清液能明显抑制CIK的增殖率和杀伤活性 ,免疫表型亦有显著的变化 (P <0 0 5 )。结论 K5 6 2和HL 6 0培养上清液能抑制脐带血CIK细胞的活性 。 Objective To investigate the effects of cultural supernanant of tumor cells on cytokine induced killer cells(CIKs) in vitro in cord blood.Methods CIKs were derived from cord blood monocytes.The cultural supernanants of K562 and HL 60 cells were added and the growth of CIKs was observed.The CIKs in routine culture were used as contrals.The cytotoxicity against K562 and HL 60 target cells was measured by MTT method.Immune phenotypes of CIKs were analyzed by FACS.Result Cord blood CIKs were heterogenic cell population consisting of mainly CD3 +T cells.The ration of CD3 +CD56 + cells increased as culture continued.CIK added with the supernanant of tumor cells exhibited some defects over CIK alone in cytotoxicity,immunotypes,proliferation( P <0 05).Conclusion The activity of cord blood of CIKs were inhibited by supernanant of tumor cells.
出处 《临床检验杂志》 CAS CSCD 北大核心 2002年第2期84-86,共3页 Chinese Journal of Clinical Laboratory Science
关键词 脐带血 细胞因子诱导 杀伤细胞 肿瘤细胞 培养上清 Supernanant Tumor cells Cord blood CIKs Cytotoxicity Inhibit
  • 相关文献

参考文献10

  • 1Rosenberg SA.Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukine-2[J].Important advances in oncology,1986,55-91.
  • 2Rosenstein M,Yron I.Lymphokine-activated killer cells:Lysis of fresh syngeneic NK-resistant murine tumor cells by lymphocytes cultured in interleukin 2[J].Cancer Res,1984,441946.
  • 3Rosenberg SA,Spiess PS,Lafreniere R.A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes[J].Science,1986,2331318-1321.
  • 4Anderson PM,Blzar BR,Bach FH,et al.Anti-CD3+ IL-2 stimulated murine killer cells[J].J Immunol,1989,1421383.
  • 5Lu P-H,Negin RS.A noval population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severs combined immunodeficiency[J].J Immunol,1994,1531687.
  • 6Mehta BA,Schmidt-Wolf,Ingo GH,et al.Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+CD56+ killer cells[J].Blood,1995,86(9)3493.
  • 7田志刚,张建华.MTT法在检测细胞因子与细胞毒效应中的应用[J].中国肿瘤生物治疗杂志,1994,1(1):74-79. 被引量:20
  • 8施广霞,程一櫂,郭连英,王艳,钱振超.CD_3AK细胞介导的MHC非限制性溶瘤作用机制的初步研究[J].中国肿瘤生物治疗杂志,1996,3(3):211-213. 被引量:8
  • 9Lu P-H,Negin RS.A noval population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mic with severe combined immunodeficiency[J].J Immunol,1994,1531687.
  • 10宋文刚,于益芝,曲迅,刘书逊,王闻雅,张明徽,唐玲,厉永建,曹雪涛.肿瘤细胞培养上清对小鼠骨髓来源的树突状细胞分化发育的影响[J].中国肿瘤生物治疗杂志,2001,8(2):134-134. 被引量:14

二级参考文献20

  • 1田志刚,孙汭,张捷,张建华,刘杰,田彤,明雨,崔正言.IL-6依赖细胞株的克隆化、冻存及其应用[J].免疫学杂志,1994,10(1):52-55. 被引量:4
  • 2张志强,田志刚,崔正言,张健华,张捷.MTT法检测人胎脾巨噬细胞细胞毒效应的建立[J].上海免疫学杂志,1994,14(1):48-48. 被引量:8
  • 3刘乐琴,程一櫂,柯丹兵,袁保和,郭连英,王艳,钱振超.PHA-LAK与常规LAK细胞生物学特性的比较[J].上海免疫学杂志,1994,14(6):321-324. 被引量:9
  • 4[1]Steinman, RM. The dendritic cell system and its role in immunogenicity [J]. Annu Rev Immunol, 1991, 9: 271-296.
  • 5[2]Restifo NP. Not so FAS: Re-evaluating the mechanisms of immune privilege and tumor escape [J]. Nat Med, 2000, 6(5): 493-495.
  • 6[3]Heufler C, Koch F, Stanzl U, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells [J]. Eur J Immunol, 1996, 26(3): 659-668.
  • 7[4]Cao X, Zhang W, Wang J, et al. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells [J]. Immunology, 1999, 97(7): 616-625.
  • 8[5]Van Gool SW, de Boer M, Ceuppens JL. The combination of anti-B7 monoclonal antibody and cyclosporin a induces alloantigen-specific anergy during a primary mix lymphocytes reaction [J]. J Exp Med, 1994, 179(2): 715-720.
  • 9[6]Judge TA, Tang A, Turka LA. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals [J]. Immunol Res, 1996, 5(1): 38-49.
  • 10[7]Lamont AG, Adorini L. IL-12, a key cytokine in immune regulation [J]. Immunol Today, 1996, 17(5): 214-217.

共引文献38

同被引文献19

  • 1Schmidt-Wolf IG, Negrin RS, Kiem HP, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[ J ] .J Exp Med, 1991,174( 1 ) : 139-149.
  • 2Lu PH, Negrin RS. A novel population of expanded human CD3^+ CD^+56 cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[ J ] .J lmmunol, 1994,153(4) :1687-1696.
  • 3Schmidt-Wolf lG,Lefterova P, Mehta BA, et al. Phenotypic characterization and identification of effector cells involved in tumor cell recagnition of cytokine-induced killer cells [ J ]. Exp Hematol, 1993,21 ( 13 ) :1673-1679.
  • 4Sehmidt-Wolf IG, Lefterova P, Johnston V, et al. Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells[J]. Cell lmmunol, 1996, 169(1) :85-90.
  • 5Mehta BA, Schmidt-Wolf IG, Weissman IL, et al. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3^+ CD^+56 killer cells [ J ]. Blood, 1995, 86 ( 9 ) : 3493-3499.
  • 6Verneris MR,Kornacker M. Mailander V. et al. Resistance of ex vivo expanded CD3^+ CD^+56 T cells to Fas-mediated apoptosis[J]. Cancer lmmunol lmmunother.2000.49(6) :335-345.
  • 7Zoll B, Lefterova P, Ebert O, et al. Modulation of cell surface markers on NK - like T lymphocytes hy using IL-2,IL-7 or IL-12 in vitro stimulation[J]. Cytokine, 2000, 12(9) : 1385-1390.
  • 8Zoll B, Lefterova P, Csipai M, et al. Generation of cytokine-induced killer cells using exogenous interleukin-2,-7 or -12[J]. Cancer lmmunol lmmunother, 1998,47(4) :221-226.
  • 9Scheffold C, Brandt K, Johnston V, et al. Potential of autologous immunological effector cells for bone marrow purging in patients with chronic myeloid leukemia[J]. Bone Marrow Transplant, 1995,15( 1 ) :33-39.
  • 10任欢,邢淑贤,徐红薇,宋英晖,商晓舟,周贵生,田景先,李殿俊.CIK的体外增殖及体内外杀瘤活性的实验研究[J].中国肿瘤生物治疗杂志,1999,6(1):17-21. 被引量:66

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部